Revenue surge masks margin miss; policy clarity needed for H2
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Revenue/PAT targets beat. EBITDA/NPM guidance missed. Management deferring next quarters' outlook is cautious signal.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Exceptional topline growth (130% YoY, business doubled) is real and driven by PM Surya Ghar subsidy tailwind + expanded distribution. But Q2 EBITDA margin (17.1%) and PAT margin (10.2%) both undershot prior guidance (18-19% and 11-13%), signalling execution pressure. Inventory explosion (₹910 Cr to ₹1,230 Cr) and negative FCF despite doubled revenue are red flags. Management explicitly deferred H2 guidance, citing regulatory uncertainty on ALMM List-II and PM Surya Ghar 2.0 approval—suggesting confidence is conditional. Hold until clarity emerges on margin recovery and policy tailwinds.
₹1306.8 Cr
Revenue · +130.1% YoY₹132.9 Cr
Reported PAT · +111.2% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue grew 130% to ₹1,307 Cr in Q2
METDelivered ₹1,306.8 Cr, YoY +130.1%; matches management's stated ₹1,307 Cr
EBITDA grew 116% to ₹223 Cr in Q2
METEBITDA implied from 17.1% OPM on ₹1,306.8 Cr = ₹223.2 Cr; YoY growth ~116% matches
PAT doubled, up 111% to ₹133 Cr
METDelivered ₹132.9 Cr, YoY +111.2%; matches mgmt claim within rounding
EBITDA margin sustainable at 18-19% per guidance
OVERSTATEDQ2 delivered 17.1%, below 18-19% guided range; Q1 was 18.9%, so 180 bps QoQ decline
Doubled business in a year
METH1 FY27 revenue ₹2,652 Cr vs full-year FY26 ~₹2,655 Cr; supported
Earnings quality
What changed since the last call
Margin guidance miss, Q2 execution
DowngradeQ2 OPM 17.1% vs 18-19% guidance; NPM 10.2% vs 11-13% guidance. Prior Q1 was 18.9%, so QoQ decline 180 bps. Cited Ratlam ramp overheads, seasonal softness, elevated freight. Guidance now in question.
Revenue growth beat expectations
UpgradeQ2 revenue up 130% YoY vs FY27 full-year guidance of 70%. H1 trajectory shows business can double in a year. Surya Ghar subsidy proving immense tailwind.
Inventory discipline worsened
DowngradeInventory rose ₹320 Cr to ₹1,230 Cr in H1. Post-Bawal fire, buying tubular batteries externally. ALMM List-II pending, so stocking ahead of mandate. WC days fell only 24 despite 130% growth—shows buildup.
Debt & capex trajectory
NeutralNet debt ₹800 Cr (up from ₹600 Cr post-Bawal loss). Ratlam capex ₹184 Cr in H1; total capex ₹661 Cr in H1 vs ₹500 Cr full-year target. On track but consuming cash. Management expects to reduce debt post-insurance claim and as inventory normalizes.
The Q&A
Analysts (IIFL, Spark Capital) pressed hard on margin compression, cash flow, debt, oversupply, and H2 growth. Management partially hedged—acknowledged Ratlam ramp costs and inventory buildup, but deflected margin-recovery timing to Q3 results. On Surya Ghar dependency, explicitly deferred forward guidance until policy clarity. Tone was candid on near-term headwinds but confident on long-term structural growth. Did not break under pressure.
Second half growth guidance — Prithvi Raj, IIFL
PartialWe want to revise guidance after Q3 results. Variable factors like ALMM List-II at the door and PM Surya Ghar 2.0 clarity pending. We will not revise guidance this time, but see more clarity in Q4.
Margin sustainability — Prithvi Raj, IIFL
DodgedIt will be sustainable as per our last guidance, basically.
Cell margins vs peers — Himanshu Bisani, PinPoint X
AnsweredWe are B2C-focused, not pure cell players. We sell DCR, non-DCR, and lithium products. Complete system + service moat sustains margins. Government policy (ALMM List-II, DCR shortages) affects our mix. We want to maintain current margins, not be aggressive.
PM Surya Ghar 2.0 upside — Himanshu Bisani, PinPoint X
PartialWe've been in battery business 30 years. If policy comes, it directly suits us. We think we'll get much better market share than today.
DCR cell sourcing — Shwetha, thoughtPMS
AnsweredAround 70%-80% in-house and 20%-30% DCR from outside.
Subsidy revenue mix — Shwetha, thoughtPMS
AnsweredMore than 50% of our revenue comes from on-grid and DCR-based market.
Capacity and oversupply — Sagar Shah, Spark Capital
AnsweredDCR cell shortage is real. ALMM-2 will shift market to DCR. Panel capacity 3.5 GW + cell 2.2 GW. If ALMM-2 and Surya Ghar 2.0 come, we don't have overcapacity. If deferred, we may source cells externally next year. No overcapacity now.
Expense growth vs revenue growth — Sagar Shah, Spark Capital
AnsweredRatlam facility capitalized Aug '26, so overheads now in opex. Fixed costs spread better next year. Selling/distribution expanded, freight/diesel costs up, deliberate Tier 2-3 brand campaigns.
Cash flow and debt — Sagar Shah, Spark Capital
AnsweredInventory rising due to Bawal fire (now buying tubular batteries externally), ALMM List-II pending (pre-stocking). We expect normalization. Debt for Ratlam capex. Insurance claim on Bawal will come through in FY27, reducing debt. Expect debt rationalization and cash improvement post Q4.
Guidance
FY27 revenue growth 70% (raised from prior 50%)
HighGiven in Q1 FY27 call. H1 achieved 127% growth, well ahead. But Q2 was QoQ -2.9%, suggesting H2 moderation likely.
FY27 EBITDA margin 18-19%
MediumQ2 delivered 17.1%, missing range. Management confident it's 'sustainable' as guided but evidence shows compression. Ratlam ramp cited as temporary.
PAT margin target 11-13% for FY27
MediumQ2 delivered 10.2%, below range. Movement in line with EBITDA margin miss (180 bps QoQ compression flows through P&L).
EBITDA margin sustainable at 18-19%
LowDespite confident tone, Q2 is 120 bps below guidance midpoint. Management deferred H2 guidance revision until Q3 results. Suggests uncertainty.
FY27 capex ₹500 Cr (debt ₹200 Cr + operations ₹300 Cr)
HighH1 capex ₹661 Cr already in place. Ratlam facility ramp (panels, cells, batteries, inverters), Hathras tubular batteries, lithium-ion expansion. On track.
Risks the call surfaced
Policy dependency
High50%+ revenue from PM Surya Ghar Phase 1. Phase 2.0 not approved; if delayed or scope reduced, growth stalls. ALMM List-II mandate Jan 2027 could disrupt supply chain if DCR cell production doesn't scale.
Margin compression
HighQ2 OPM 17.1% down 180 bps QoQ despite 130% revenue growth. Below 18-19% guidance. Ratlam ramp, freight inflation, distribution expansion cited; but no clear path to margin recovery in H2.
Inventory management
HighInventory rose ₹320 Cr (₹910 Cr to ₹1,230 Cr) in H1. Post-Bawal fire, sourcing tubular batteries externally. ALMM List-II pending, so pre-stocking DCR capacity. WC days only improved 24 days despite doubled revenue—signals buildup risk.
Debt escalation
MediumNet debt ₹800 Cr (debt/equity 0.55x). H1 capex ₹661 Cr + WC needs consumed all ₹490 Cr OCF. Debt-to-equity manageable now, but negative FCF can push leverage higher if not corrected.
Competitive intensity
MediumLarge solar module manufacturers (Canadian Solar, JinkoSolar, etc.) and new DCR cell makers entering rooftop market. PM Surya Ghar subsidy attracts competition. Price deflation risk on cells and modules.
Management
Score 7/10. Candid on challenges (Bawal fire, Ratlam ramp costs, inventory buildup); less transparent on margin recovery timeline. Deferred H2 guidance, citing policy uncertainty—cautious but credible. Q2 revenue beat guidance (130% vs 70% FY27 target). PAT beat (111% vs guided 11-13% margin). But EBITDA margin miss (17.1% vs 18-19%) signals execution gap on cost control.
1 · Jan 01, 2027
ALMM List-II mandate: all rooftop solar must use DCR cells. Market will shift; impact unclear.
2 · Gov. decision TBD
PM Surya Ghar 2.0 approval. Phase 1 covered 60+ lakh homes; 2.0 could unlock battery storage subsidy, structural margin lift.
3 · Q3 FY27 (Jan '27)
Results will clarify H2 trajectory, margin recovery, and second-half guidance. Management will update after seeing Q3 data.
Hold until clarity emerges on margin recovery and policy tailwinds.
Informational and educational content only. Not investment advice.